COLOMBI, ANNALISA
COLOMBI, ANNALISA
Universita' degli Studi di MILANO
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis : correlation with CSF β-amyloid levels and brain volumes
2019 A.M. Pietroboni, T. Carandini, A. Colombi, M. Mercurio, L. Ghezzi, G. Giulietti, M. Scarioni, A. Arighi, C. Fenoglio, M.A. De Riz, G.G. Fumagalli, P. Basilico, M. Serpente, M. Bozzali, E. Scarpini, D. Galimberti, G. Marotta
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?
2019 A. Arighi, A. Di Cristofori, C. Fenoglio, S. Borsa, M. D'Anca, G.G. Fumagalli, M. Locatelli, G. Carrabba, A.M. Pietroboni, L. Ghezzi, T. Carandini, A. Colombi, M. Scarioni, M.A. De Riz, M. Serpente, P.M. Rampini, E. Scarpini, D. Galimberti
CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis
2020 A.M. Pietroboni, F. Schiano di Cola, A. Colombi, T. Carandini, C. Fenoglio, L. Ghezzi, M.A. De Riz, F. Triulzi, E. Scarpini, A. Padovani, D. Galimberti
CSF β-amyloid predicts prognosis in patients with multiple sclerosis
2019 A.M. Pietroboni, M. Caprioli, T. Carandini, M. Scarioni, L. Ghezzi, A. Arighi, S. Cioffi, C. Cinnante, C. Fenoglio, E. Oldoni, M.A. De Riz, P. Basilico, G.G. Fumagalli, A. Colombi, G. Giulietti, L. Serra, F. Triulzi, M. Bozzali, E. Scarpini, D. Galimberti
Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation
2017 L. Ghezzi, T. Carandini, A. Arighi, C. Fenoglio, M. Arcaro, M. De Riz, A.M. Pietroboni, G.G. Fumagalli, P. Basilico, A. Calvi, M. Scarioni, A. Colombi, M. Serpente, G. Marotta, R. Benti, E. Scarpini, D. Galimberti
Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis : a longitudinal OCT study
2020 A.M. Pietroboni, T. Carandini, L. Dell'Arti, F. Bovis, A. Colombi, M.A. De Riz, E. Casazza, E. Scola, C. Fenoglio, A. Arighi, G.G. Fumagalli, F. Triulzi, D. Galimberti, F. Viola, E. Scarpini
Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study
2020 A.M. Pietroboni, T. Carandini, L. Dell'Arti, F. Bovis, A. Colombi, M.A. De Riz, E. Casazza, E. Scola, C. Fenoglio, A. Arighi, G.G. Fumagalli, F. Triulzi, D. Galimberti, F. Viola, E. Scarpini
Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis
2023 A.M. Pietroboni, A. Colombi, V.E. Contarino, F.M.L. Russo, G. Conte, A. Morabito, S. Siggillino, T. Carandini, C. Fenoglio, A. Arighi, M.A. De Riz, M. Arcaro, L. Sacchi, G.G. Fumagalli, A.M. Bianchi, F. Triulzi, E. Scarpini, D. Galimberti
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes
2019 T. Carandini, ARIGHI ANDREA, L. Sacchi, FUMAGALLI GIORGIO GIULIO, PIETROBONI ANNA MARGHERITA, L. Ghezzi, COLOMBI ANNALISA, SCARIONI MARTA, C. Fenoglio, DE RIZ MILENA ALESSANDRA, G. Marotta, E. Scarpini, GALIMBERTI DANIELA
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients
2019 A.M. Pietroboni, L. Dell'Arti, M. Caprioli, M. Scarioni, T. Carandini, A. Arighi, L. Ghezzi, G.G. Fumagalli, M.A. De Riz, P. Basilico, A. Colombi, E. Benatti, F. Triulzi, E. Scarpini, F. Viola, D. Galimberti
The Role of Amyloid-β in White Matter Damage: Possible Common Pathogenetic Mechanisms in Neurodegenerative and Demyelinating Diseases
2020 A.M. Pietroboni, A. Colombi, T. Carandini, E. Scarpini, D. Galimberti, M. Bozzali